STOCK TITAN

Iveda Solutions Warrant (IVDAW) 10-Q Filings

IVDAW NASDAQ

Here are the 10-Q quarterly reports from Iveda Solutions, Inc. Warrant (IVDAW) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-Q covers the quarterly report filed between annual reports, so if you follow IVDAW and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full IVDAW filings page.

Rhea-AI Summary

Iveda Solutions, Inc. reported lower revenue but improved gross profit for the six months ended June 30, 2026. Total revenue was $2.30 million, down from $3.00 million a year earlier, driven mainly by reduced equipment sales in both the U.S. distributor channel and Taiwan government contracts due to delivery timing.

Gross profit increased to $0.93 million from $0.73 million, reflecting a higher mix of higher-margin contracts in both regions. The company recorded a net loss of $1.33 million, similar to the prior-year period. Cash, restricted cash and cash equivalents totaled $4.83 million, and management expects this to fund the current operating plan for at least twelve months from the financial statement issuance date.

Iveda strengthened its capital position through a February 2026 public offering and warrant exercises, issuing over 5.7 million new common shares and new warrants, and ending the period with 12,519,027 shares outstanding. Revenue remains highly concentrated, with 72% of first-half 2026 revenue coming from three Taiwan customers. Management disclosed that disclosure controls and procedures and internal control over financial reporting were not effective as of June 30, 2026, and the company continues to report recurring operating losses while pursuing growth in AI-driven smart city and IoT solutions.

Rhea-AI Summary

Iveda Solutions reported Q1 2026 revenue of $1.49 million, up slightly from $1.47 million a year earlier, driven mainly by higher Taiwan government project sales. Gross profit rose to $0.50 million, improving margin as cost of revenue fell. The company still posted a net loss of $0.53 million, narrower than the prior-year loss of $0.79 million, and used $0.9 million of cash in operations.

During the quarter Iveda raised net proceeds of about $1.6 million through a February 2026 equity offering, doubling common shares outstanding to 11.6 million and ending the period with $5.7 million in cash. Management concluded this cash should fund the operating plan for at least 12 months, though the company continues to carry an accumulated deficit and relies heavily on a few large Taiwan customers. Internal control over financial reporting and disclosure controls were assessed as not effective due to material weaknesses, which management is working to remediate.